Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients

Cancer

Volumn 74, Issue 5, 1994, Pages 1575-1583

  Esteban, Jose M ^a   Felder, Barbara ^a   Ahn, Chul ^a   Simpson, Jean F ^a   Battifora, Hector ^a   Shively, John E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

breast cancer; carcinoembryonic antigen; estrogen receptors; immunohistochemistry; prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN; ESTROGEN RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RISK; DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CARCINOMA IN SITU; CARCINOMA, INFILTRATING DUCT; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0028022877     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940901)74:5<1575::AID-CNCR2820740513>3.0.CO;2-W     Document Type: Article

References (42)

1. Clinical value of carcinoembryonic antigen
2. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease
3. Carcinoembryonic antigen expression and patient survival in carcinoma of the breast
4. Carcinoembryogenic antigen: its role as a marker in the management of cancer: National Institutes of Health Consensus Development Conference Statement
5. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen
6. The clinical value of tissue carcinoembryonic antigen in breast cancer
7. Carcinoembryonic antigen in breast cancer tissue: a useful prognostic indicator
8. Tissue and plasma carcinoembryonic antigen in early breast cancer: a prognostic factor
9. The distribution of carcinoembryonic antigen in breast carcinoma: diagnostic and prognostic implications
10. Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma
11. Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique
12. CEA positivity in sera and breast tumor tissues obtained from the same patients
13. Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival
14. Carcinoembryonic antigen immunocytochemistry in primary breast cancer
15. Carcinoembryonic antigen and steroid receptors in the cytosol of carcinoma of the breast relationship to pathologic and clinical features
16. Antigenic sites in carcinoembryonic antigen
17. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies
18. Cloning for the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human‐mouse T84.66 genes in myeloma and Chinese hamster ovary cells
19. Sensitivity and specificity of Gold types 1 to 5 anti‐carcinoembryonic antigen monoclonal antibodies: immunohistologic characterization in colorectal cancer and normal tissues
20. Estrogen receptor immunohistochemical assay in paraffin‐embedded tissue: a better gold standard?
21. Immunohistochemical assay of neu/c‐erbB‐2 oncogene product in paraffin‐embedded tissues in early breast cancer: retrospective follow‐up study of 245 Stage I and II cases
22. Biological markers for breast carcinoma
23. Immunohistochemical detection of carcinoembryonic antigen in conventional histopathology specimens
24. A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products
25. Definition of the expression of the human carcinoembryonic antigen and nonspecific cross‐reacting antigen in human breast and lung carcinomas
26. CEA and HMFG in hyperplastic and malignant lesions of the breast
27. Assessment of antigen damage in immunohistochemistry: the vimentin internal control
28. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) in 120 mammary carcinomas and its correlation with tumor type, grading, staging plasma‐cea, and biochemical receptor status
29. Tissue carcinoembryonic antigen and estrogen receptor in human breast cancer
30. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue relationship with the receptor content in breast carcinoma
31. CEA and NCA in bening and malignant breast tumors
32. Cardoso de Almeida PC. Tissue carcinoembryonic antigen in the prognosis of early invasive breast cancer
33. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
34. Prognostic cancer in breast cancer
35. Assessing the risk of recurrence in breast cancer
36. Conceptual and practical advances in the management of breast cancer
37. Estrogen staining in breast carcinoma by PAP methods compared to CEA and ferritin staining
38. Correlation of estrogen receptor protein and carcinoembryonic antigen with lymphnodal metastasis in breast carcinoma